Drug Design Expert Witnesses
Drug design disputes in complex commercial litigation typically center on patent validity, licensing, and regulatory questions involving how a pharmaceutical compound was designed and optimized, arising when companies disagree over whether a claimed drug design mechanism is novel, whether licensed drug design technology was used as permitted, or whether disclosed research data support a patent or regulatory claim. These disputes surface in pharmaceutical patent litigation over small molecule and biologic drug design, in licensing disputes over the scope of permitted use for computational drug design platforms and chemical libraries, and in disputes over whether preclinical drug design data accurately support a company's scientific or regulatory representations. Because drug design mechanisms are technical enough that reasonable medicinal chemists can characterize the same experimental data differently, the central issue is typically whether the underlying drug design evidence supports the scientific, patent, or regulatory position a party has taken.
A drug design expert helps attorneys evaluate that evidence by applying accepted medicinal chemistry and computational drug design methods to the mechanism at issue. That might mean assessing whether prior art drug design research anticipates or renders obvious a claimed compound or design methodology, evaluating whether a licensee's use of a computer-aided drug design platform stayed within the scope of a license agreement, or analyzing whether preclinical drug design data support a company's scientific claims. This analysis supports positions on patent validity, breach of license terms, and regulatory compliance, giving attorneys a scientifically grounded basis for litigation strategy.
Drug design cases benefit from experts whose specific research background, whether medicinal chemistry, computer-aided drug design, or structure-activity relationship analysis, matches the precise drug design mechanism at issue rather than drug design in general terms. Round Table Group's drug design network includes medicinal chemists, biochemists, and bioinformatics researchers with published work spanning drug design, protein physics, and toxicology, several of whom have testified in patent and licensing matters. With more than 75,000 expert searches completed for litigators, we help attorneys match a case's specific drug design question to an expert whose scientific credentials will withstand scrutiny. Let us help you find the right drug design expert for your case by calling us at (202) 908-4500.